23.81k followers • 13 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
---|---|---|---|---|
The Fight Against COVID19 | +0.19% | - | - | - |
^GSPC | +1.02% | -2.94% | +22.32% | +5383.83% |
Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 146.14 | -0.68 | -0.46% | 4:00 PM EDT | 6.13M | 7.64M | 352.17B |
ABBV | AbbVie Inc. | 159.62 | -7.67 | -4.58% | 4:00 PM EDT | 10.63M | 5.71M | 282.63B |
PFE | Pfizer Inc. | 25.4 | +0.14 | +0.55% | 4:01 PM EDT | 46.01M | 42.28M | 143.83B |
SNY | Sanofi | 49.13 | -0.23 | -0.47% | 4:00 PM EDT | 4.14M | 2.05M | 122.65B |
REGN | Regeneron Pharmaceuticals, Inc. | 883.2 | -7.48 | -0.84% | 4:00 PM EDT | 502.94k | 467.06k | 96.94B |
GSK | GSK plc | 41.11 | +0.20 | +0.49% | 4:00 PM EDT | 2.55M | 3.48M | 83.99B |
GILD | Gilead Sciences, Inc. | 65.42 | +0.15 | +0.23% | 4:00 PM EDT | 12.35M | 7.43M | 81.58B |
MRNA | Moderna, Inc. | 107.97 | +1.79 | +1.69% | 4:00 PM EDT | 2.24M | 3.76M | 41.34B |
TAK | Takeda Pharmaceutical Company Limited | 13.03 | -0.04 | -0.31% | 4:00 PM EDT | 1.21M | 1.83M | 41.23B |
BNTX | BioNTech SE | 87.21 | +0.50 | +0.58% | 4:00 PM EDT | 348.30k | 589.29k | 21.02B |
VIR | Vir Biotechnology, Inc. | 8.23 | +0.60 | +7.86% | 4:00 PM EDT | 1.09M | 1.06M | 1.12B |
NVAX | Novavax, Inc. | 4.09 | +0.14 | +3.54% | 4:00 PM EDT | 3.01M | 7.13M | 572.41M |
INO | Inovio Pharmaceuticals, Inc. | 10.57 | +0.44 | +4.40% | 4:00 PM EDT | 193.22k | 475.16k | 273.83M |
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
One thing is for sure: Dividend seekers can't go wrong with either.
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...